Federation Des Caisses Desjardins Du Quebec Biotechnology

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
SRPT Sarepta Therapeutics, Inc.	$10.7B	$6,000 0.0% of portfolio	50	Q3 2024 New
SILO Silo Pharma, Inc.	$3.01M	$6,000 0.0% of portfolio	6,000	Q3 2024 New
PCVX Vaxcyte, Inc.	$5.1B	$6,000 0.0% of portfolio	56	Q3 2024 New
ARCT Arcturus Therapeutics Holdings Inc.	$439M	$5,000 0.0% of portfolio	245	Q3 2024 Added 63.33%
ALLK Allakos Inc.	$109M	$4,000 0.0% of portfolio	6,200	Q3 2023 Reduced 8.49%
ABOS Acumen Pharmaceuticals, Inc.	$71.7M	$3,000 0.0% of portfolio	1,500	Q3 2024 New
ABUS Arbutus Biopharma Corp	$478M	$3,000 0.0% of portfolio	800	Q2 2017 Reduced 20.0%
NTLA Intellia Therapeutics, Inc.	$916M	$3,000 0.0% of portfolio	181	Q3 2018 Sold Out
RPTX Repare Therapeutics Inc.	$56.6M	$3,000 0.0% of portfolio	1,109	Q1 2021 Added 15.67%
CVAC Cure Vac N.V.	$561M	$2,000 0.0% of portfolio	950	Q4 2020 Reduced 97.47%
INMB Inmune Bio, Inc.	$81.7M	$2,000 0.0% of portfolio	400	Q1 2021 Reduced 50.0%
ALEC Alector, Inc.	$159M	$1,000 0.0% of portfolio	415	Q3 2024 Reduced 8.79%
ARDX Ardelyx, Inc.	$742M	$1,000 0.0% of portfolio	250	Q3 2024 New
BGNE Bei Gene, Ltd.	$18.8B	$1,000 0.0% of portfolio	5	Q3 2024 New
BCYC Bicycle Therapeutics PLC	$431M	$1,000 0.0% of portfolio	61	Q2 2024 New
BDTX Black Diamond Therapeutics, Inc.	$79.6M	$1,000 0.0% of portfolio	280	Q1 2024 New
CABA Cabaletta Bio, Inc.	$65.3M	$1,000 0.0% of portfolio	340	Q1 2024 New
CRBU Caribou Biosciences, Inc.	$109M	$1,000 0.0% of portfolio	900	Q3 2023 Reduced 44.44%
EDIT Editas Medicine, Inc.	$85.9M	$1,000 0.0% of portfolio	550	Q3 2024 Added 10.0%
GLSI Greenwich Life Sciences, Inc.	$156M	$1,000 0.0% of portfolio	100	Q3 2024 New
HRMY Harmony Biosciences Holdings, Inc.	$2.02B	$1,000 0.0% of portfolio	49	Q3 2024 New
OMER Omeros Corp	$634M	$1,000 0.0% of portfolio	300	Q3 2018 Reduced 37.33%
TNYA Tenaya Therapeutics, Inc.	$65.8M	$1,000 0.0% of portfolio	1,000	Q3 2024 New
XFOR X4 Pharmaceuticals, Inc	$38.4M	$1,000 0.0% of portfolio	2,000	Q3 2024 Reduced 50.0%
ATAI Atai Life Sciences N.V.	$199M	$0 0.0% of portfolio	150	Q3 2023 Reduced 97.74%
ADAP Adaptimmune Therapeutics PLC	$96.4M	$0 0.0% of portfolio	755	Q3 2024 Reduced 3.82%
AKBA Akebia Therapeutics, Inc.	$338M	$0 0.0% of portfolio	150	Q1 2018 Sold Out
APLT Applied Therapeutics Inc.	$41.8M	$0 0.0% of portfolio	84	Q1 2024 New
AUPH Aurinia Pharmaceuticals Inc.	$1.27B	$0 0.0% of portfolio	40	Q1 2018 Added 35.23%
BTAI Bio Xcel Therapeutics, Inc.	$9.81M	$0 0.0% of portfolio	113	Q3 2021 Added 182.5%
DYN Dyne Therapeutics, Inc.	$1.24B	$0 0.0% of portfolio	20	Q3 2024 New
FATE Fate Therapeutics Inc	$161M	$0 0.0% of portfolio	95	Q4 2021 Reduced 33.68%
GOSS Gossamer Bio, Inc.	$80.8M	$0 0.0% of portfolio	750	Q3 2024 Reduced 5.06%
INM In Med Pharmaceuticals Inc.	$4.23M	$0 0.0% of portfolio	19	Q3 2024 New
NKTX Nkarta, Inc.	$122M	$0 0.0% of portfolio	100	Q2 2024 New
ONVO Organovo Holdings, Inc.	$2.96M	$0 0.0% of portfolio	3	Q3 2024 New
PLX Protalix Bio Therapeutics, Inc.	$86.6M	$0 0.0% of portfolio	250	Q4 2019 Added 340.0%
QSI Quantum Si Inc	$156M	$0 0.0% of portfolio	50	Q1 2024 New
SPRO Spero Therapeutics, Inc.	$33M	$0 0.0% of portfolio	30	Q2 2023 Added 4.29%
VXRT Vaxart, Inc.	$75.9M	$0 0.0% of portfolio	400	Q3 2024 New
VERA Vera Therapeutics, Inc.	$1.14B	$0 0.0% of portfolio	20	Q3 2024 New
VIR Vir Biotechnology, Inc.	$979M	$0 0.0% of portfolio	100	Q3 2024 Reduced 60.0%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.